πŸ‡ΊπŸ‡Έ FDA
Patent

US 10888597

Composition for treating brain stroke

granted A61KA61K36/232A61K36/236

Quick answer

US patent 10888597 (Composition for treating brain stroke) held by ENLIVEN BIOTECHNOLOGY CO, LTD. expires Mon Jan 07 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
ENLIVEN BIOTECHNOLOGY CO, LTD.
Grant date
Tue Jan 12 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 07 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
9
CPC classes
A61K, A61K36/232, A61K36/236, A61K36/258, A61K36/282